KYMR R&D to Revenue

Kymera Therapeutics Inc · R&D to Revenue

KYMR logo

KYMR R&D to Revenue

Latest reported807.65%
KYMR FY R&D/Revenue (0.00% → 807.65%)
High-resolution chart · PNG

KYMR r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
807.6531%
510.3841%
240.5856%
350.7624%
188.1275%
182.4793%
1,266.4622%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.